Description
Evrozidim (Seftazidime) Powder 1g Vial №10
Composition:
Each vial contains: Seftazidime 1g.
Mechanism of Action:
Seftazidime, a third-generation cephalosporin antibiotic, exerts its pharmacological effects by inhibiting bacterial cell wall synthesis, leading to cell death. It has broad-spectrum activity against many gram-negative bacteria.
Pharmacological Properties:
Evrozidim (Seftazidime) demonstrates potent antibacterial activity due to its ability to penetrate bacterial cells and interfere with crucial enzymatic processes, resulting in bacterial death.
Indications for Use:
Evrozidim (Seftazidime) is indicated for the treatment of infections caused by susceptible bacteria. Common indications include respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.
Contraindications:
Avoid using Evrozidim (Seftazidime) if you have a known allergy to Seftazidime or any other beta-lactam antibiotics. Use caution in patients with renal impairment to prevent potential adverse effects.
Side Effects:
- Gastrointestinal disturbances
- Allergic reactions
- Renal toxicity
- Neurotoxicity
Usage Instructions:
Evrozidim (Seftazidime) is typically administered via intravenous infusion or intramuscular injection. Dosage and duration of treatment should be individualized by a healthcare provider. For adults, the usual dose ranges from 1 to 2 grams every 8 to 12 hours.
Benefits Compared to Analogues:
Evrozidim (Seftazidime) offers superior efficacy in treating infections caused by multidrug-resistant gram-negative bacteria, including Pseudomonas aeruginosa, compared to many other antibiotics in its class.
Suitable Patient Groups:
Evrozidim (Seftazidime) is safe for use in adults, children, and elderly patients under appropriate medical supervision. Dosing adjustments may be necessary based on age and renal function.
Storage and Shelf Life:
Store Evrozidim (Seftazidime) as per the manufacturer’s instructions. Ensure proper storage conditions to maintain product stability. Check the expiration date on the packaging and do not use expired vials.
Packaging Description:
Evrozidim (Seftazidime) is available in vials containing 1g of powder for reconstitution. Each package consists of 10 vials for multiple doses.
Clinical Evidence and Proven Effectiveness:
Seftazidime has been extensively studied in clinical trials, demonstrating high efficacy in the treatment of various infections, particularly those caused by Pseudomonas aeruginosa. Clinical studies have consistently shown the effectiveness of Seftazidime in managing bacterial infections.
